Move over time in range…time in TIGHT range wants a seat at the table. But should we make room? Dr. Pettus explains what TITR is, how it developed, and whether or not it’s time to embrace it.
read more →
When Aubrey Molgaard’s young daughter Elin showed signs of type 1 diabetes, Aubrey traveled across two states to get Elin on a new medication called Tzield that delays the onset of type 1. Elin was the first child in Iowa to receive the medication, and she remains insulin free to this day.
read more →
The three determined members of team “Dia-Bet-U-Can’t-Beat-Us” had a mission greater than finishing the 70.3-mile Oceanside, CA Ironman when they competed in April, which fueled their resolve to overcome the challenges they faced in in the 1.2-mile swim, 56-mile bike ride and 13.1-mile run.
read more →
For years and years (and years), the “red suitcase” was the main glucagon rescue kit most people with type 1 diabetes had stashed somewhere in case of emergency. Thankfully, we now have two newer glucagon options that are much easier to administer. Drs. E+P explain how to use each one, and they discuss the research and off-label mini-dose glucagon experiments people are conducting that may be a mirror into the future.
read more →
A groundbreaking research program in North Carolina is screening newborns for a variety of conditions, including T1D. This unique program uses advanced genetic testing, and scientists there are hoping to use DNA research to predict more accurately who may develop T1D based on genetics.
read more →
